Diabetic edema eye, Fájl:Fundus Diabetic macular edema EDA04.JPG
- Szemészet, ( évfolyam, szám) | Arcanum Digitális Tudománytár
- Diabetes impact
- DOI: Észlelés látásszázalék és célkitűzés: A Navilas® s mikropulzuslézerrel végzett kezelés biztonságosságának és hatásosságának vizsgálata diabeteses maculaoedemában.
Szemészet, Safety and efficacy of infliximab and adalimumab for refractory uveitis in juvenile idiopathic arthritis.
J Rheumatol Jan ; 40 1 : Superior efficacy of adalimumab in treating childhood refractory chronic uveitis when used as first biologic modifier drug: Adalimumab diabetic edema eye starting anti-TNF-alpha therapy in childhood chronic uveitis.
Pediatr Rheumatol Online J ; 11 1 : Treatment of refractory uveitis with adalimumab: prospective multicenter study of patients.
Ophthalmology ; 8 : Rituximab for uveitis. Ophthalmology ; 1 : Heiligenhaus A, Miserocchi E, Heinz C, et al Treatment of severe uveitis associated with juvenile idiopathic arthritis with anti-CD20 monoclonal antibody rituximab] Rheumatology ; 50 8 : Myers Diabetic edema eye, et al.
Retinal function and morphology in the rabbit eye after intravitreal injection of the TNF alpha inhibitor adalimumab. Curr Eye Res Nov; 39 11 : Transl Vis Sei Technoi Mar 10; 4 2 : 4.
Tocilizumab in severe and refractory non-infectious uveitis. Clin Exp Rheumatol. Stewart MW. Poor Gy. A reumatológia tankönyve Medicina Könyvkiadó; Daniel É Martin, Maureen G. Maguire, Stuart L. Fine, et al.
Ophthalmology Jut 7 : Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med ; Ranibizumab for neovascular age-related macular degeneration.
More detailed information about the symptoms, causes, and treatments of Retinal edema.
Intravitreal bevacizumab Avastin for neovascular age-related macular degeneration. Ophthalmology ; N Engl J Med Mar 26; 13 : Diabetic Retinopathy Clinical Research Network.
A phase II randomized clinical trial of intravitreal bevacizumab for diabetic macular edema. Ophthalmology ; A prospective randomized trial of intravitreal bevacizumab or laser therapy in the management of diabetic macular edema BOLT study month data: report 2.
Advanced Eye Research Associates Rövid összefoglaló To assess the biomarker profile in diabetic macular edema patients in response to intravitreal aflibercept injection. Patients with diabetic macular edema who meet study requirements will receive monthly intravitreal injections of aflibercept as approved by FDA for a period of 6 months. A small quantity of fluid will be removed from the vitreous at each injection for laboratory evaluation of biomarkers present before, during and after treatment with aflibercept.
Intravitreal bevacizumab plus grid laser photocoagulation or intravitreal bevacizumab or grid laser photocoagulation for diffuse diabetic macular edema: results of the Pan-American Collaborative Retina Study Group at 24 months.
Retina ; Intravitreal aflibercept for diabetic macular edema.
Two-year outcomes of intravitreal bevacizumab therapy for macular oedema secondary to branch retinal vein occlusion. Br J Ophthalmol ; 98 2 : Szepessy Zsuzsanna, E-mail: szepzsu yahoo.
GmbH Ismaning, Ada Orzi kezelés cukorbetegség Kapható a gyógyszertárakban és a fitotékákban.